Trade CTSO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Cytosorbents Corporation (CTSO) is trading at US$5.75, down 0.17% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$23.25M. Over the past 52 weeks, CTSO has traded between US$0.30 and US$7.44. On Syfe you can trade CTSO with $0 commission and add it to your watchlist.
| Previous close | US$5.76 |
|---|---|
| Market cap | US$23.25M |
| 52-week range | US$0.30 – US$7.44 |
| Volume | 11.77K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cytosorbents Corporation
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
Year: 2005
Cytosorbents Corporation (CTSO) stock is trading at US$5.75, -0.17% from the previous close of US$5.76.
The market cap for Cytosorbents Corporation (CTSO) stock is approximately US$23.25M.
The 52-week high for Cytosorbents Corporation (CTSO) stock is US$7.44.
The 52-week low for Cytosorbents Corporation (CTSO) stock is US$0.30.
Cytosorbents Corporation (CTSO) does not currently pay a dividend.
Stay on top of CTSO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
